Form D · Biotechnology

Arkis BioSciences Inc.

Knoxville, TN · CIK 0001679188

Offering snapshot reported Aug 29, 2018 · SEC filing

Reported sold
$3.35M
Offering amount: $3.35M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 17, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.68M$3.35MJul 11, 2016: $2,325,000.00Jul 11, 2016Aug 29, 2018: $3,352,500.00Aug 29, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,325,000 → $3,352,500

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 29, 2018Amendment$3,352,500$1,027,500vs Jul 11, 20168SEC filing
Aug 29, 2018Initial$4,483,500No comparison25SEC filing
Jul 11, 2016Initial$2,325,000No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-266708

Source: Form D, filed Aug 29, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Stephen Arnold Executive
Quentin Aten Executive
James A. Killeffer, M.D. Director, Executive
Clif Moyers Director
Chad E. Seaver Director, Executive
Ken Woody Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2704 Cherokee Farm Way Suite 204
Knoxville, TN, 37920